US opens COVID boosters to all adults, urges them for 50+
November 20, 2021
WASHINGTON (AP) — The U.S. on Friday opened COVID-19 booster shots to all adults and took the extra step of urging people 50 and older to seek one, aiming to ward off a winter surge as coronavirus cases rise even before millions of Americans travel for the holidays.
Until now, Americans faced a confusing list of who was eligible for a booster that varied by age, their health and which kind of vaccine they got first. The Food and Drug Administration authorized changes to Pfizer and Moderna boosters to make it easier.
Under the new rules, anyone 18 or older can choose either a Pfizer or Moderna booster six months after their last dose. For anyone who got the single-dose Johnson & Johnson vaccine, the wait already was just two months. And people can mix-and-match boosters from any company.
“We heard loud and clear that people needed something simpler — and this, I think, is simple,” FDA vaccine chief Dr. Peter Marks told The Associated Press.
The Centers for Disease Control and Prevention had to agree before the new policy became official late Friday. CDC Director Dr. Rochelle Walensky endorsed a recommendation from her agency’s scientific advisers that — in addition to offering all adults a booster — had stressed that people 50 and older should be urged to get one.
“It’s a stronger recommendation,” said CDC adviser Dr. Matthew Daley of Kaiser Permanente Colorado. “I want to make sure we provide as much protection as we can.”
The CDC also put out a plea for those who had previously qualified but hadn’t yet signed up for a booster to quit putting it off — saying older Americans and people with risks such as obesity, diabetes or other health problems should try to get one before the holidays.
The expansion makes tens of millions more Americans eligible for an extra dose of protection.
The No. 1 priority for the U.S., and the world, still is to get more unvaccinated people their first doses. All three COVID-19 vaccines used in the U.S. continue to offer strong protection against severe illness, including hospitalization and death, without a booster.
But protection against infection can wane with time, and the U.S. and many countries in Europe also are grappling with how widely to recommend boosters as they fight a winter wave of new cases.
"News Services" POPULAR ARTICLE
-
Israel Strikes Suspected Chemical Weapons Sites and Long-range Rockets in Syria
-
Japan’s Nikkei Stock Average Ends Higher in Choppy Trade (UPDATE 1)
-
Japan’s Nikkei Stock Average Slips on Firmer Yen amid BOJ Rate Hike Bets; Logs Worst Month since April (Update 1)
-
South Korea Ex-Defense Minister Accused of Role in Martial Law Tries to Commit Suicide, Official Says
-
Japan’s Nikkei Stock Average Ends Lower as Traders Book Profits, Assess US Data (Update 1)
JN ACCESS RANKING
- Japan’s Kansai Economic Delegation Meets China Vice Premier, Confirm Cooperation; China Called to Expand Domestic Demand
- Yomiuri Stock Index to Launch in March; 333 Companies to be Equally Weighted
- China to Test Mine for Rare Metals Off Japan Island; Japan Lagging in Technologies Needed for Extraction
- Miho Nakayama, Japanese Actress and Singer, Found Dead at Her Tokyo Residence; She was 54 (UPDATE 1)
- Risk of Nuclear Weapons Being Used Greater Than Ever; Support Growing in Russia As Ukraine War Continues